Long-term mortality after acute myocardial infarction in relation to prescribed dosages of a beta-blocker at hospital discharge

Cardiovascular Drugs and Therapy

Volumn 14, Issue 6, 2000, Pages 589-595

  Herlitz, J ^a   Dellborg, M ^a   Karlson, B W ^a   Lindqvist, J ^a   Wedel, H ^b,c  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b NORDIC SCHOOL OF PUBLIC HEALTH   (Sweden)

^c NONE

Author keywords

Beta blockers; Dosage; Myocardial infarction; Prognosis

Indexed keywords

ACETYLSALICYLIC ACID; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; METOPROLOL; NITRATE; PROPRANOLOL; PSYCHOTROPIC AGENT;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BRADYCARDIA; DOSE RESPONSE; DRUG EFFICACY; DRUG FORMULATION; DRUG INDUCED DISEASE; FEMALE; HOSPITAL DISCHARGE; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME;

ACUTE DISEASE; ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; METOPROLOL; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; RISK FACTORS; SMOKING;

EID: 0034468975     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007894210131     Document Type: Article

References (20)

1. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction
2. The Beta-blocker Heart Attack Trial (BHAT)
3. Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomised trial
4. Treatment with beta-adrenergic blocking agents after myocardial infarction: From randomized trials to clinical practice
5. Beta-blocker therapy in acute myocardial infarction: Evidence for underutilization in the elderly
6. Physician use of beta-adrenergic blocking therapy: A changing perspective
7. Practices compared with practice guidelines: Use of beta-blockade after acute myocardial infarction
8. Use of beta-blocking agents in secondary prevention after myocardial infarction: A case for evidence-based medicine? GISSI experience, 1984-1993
9. Beta-blocker dosages and mortality after myocardial infarction
10. Impact of clinical trials on the use of beta-blockers after acute myocardial infarction and its relation to other risk indicators for death and 1-year mortality rate
11. Five-year mortality after acute myocardial infarction in relation to previous history, level of initial care, complications in hospital, and medication at discharge
12. Similar risk reduction of death of extended-release metoprolol once daily and immediate-release metoprolol twice daily during 5 years after myocardial infarction
13. The Göteborg Metoprolol Trial: Tolerance
14. The MIAMI Trial: Other clinical findings tolerability
15. Treatment with β-blockers - The value of an even plasma concentration over 24 h
16. Design of a new multiple-unit controlled-release formulation of metoprolol - Metoprolol CR
17. Pharmacokinetics and pharmacodynamics of controlled-release metoprolol: A comparison with atenolol
18. Controlled-release metoprolol compared with atenolol in asthmatic patients: Interaction with terbutaline